img

Global Immuno Oncology Assays Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Immuno Oncology Assays Market Research Report 2024

Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).
According to MRAResearch’s new survey, global Immuno Oncology Assays market is projected to reach US$ 9297.8 million in 2033, increasing from US$ 4439.4 million in 2022, with the CAGR of 10.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Immuno Oncology Assays market research.
Key companies engaged in the Immuno Oncology Assays industry include Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies and Illumina, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Immuno Oncology Assays were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Immuno Oncology Assays market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Immuno Oncology Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Thermo Fischer Scientific
Roche Diagnostics
Agilent Technologies
Illumina
Segment by Type
Immunoassay
Flow Cytometry
PCR
Next Generation Sequencing

Segment by Application


Research
Clinical Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Immuno Oncology Assays report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno Oncology Assays Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Immunoassay
1.2.3 Flow Cytometry
1.2.4 PCR
1.2.5 Next Generation Sequencing
1.3 Market by Application
1.3.1 Global Immuno Oncology Assays Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Research
1.3.3 Clinical Diagnostics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno Oncology Assays Market Perspective (2018-2033)
2.2 Immuno Oncology Assays Growth Trends by Region
2.2.1 Global Immuno Oncology Assays Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Immuno Oncology Assays Historic Market Size by Region (2018-2023)
2.2.3 Immuno Oncology Assays Forecasted Market Size by Region (2024-2033)
2.3 Immuno Oncology Assays Market Dynamics
2.3.1 Immuno Oncology Assays Industry Trends
2.3.2 Immuno Oncology Assays Market Drivers
2.3.3 Immuno Oncology Assays Market Challenges
2.3.4 Immuno Oncology Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno Oncology Assays Players by Revenue
3.1.1 Global Top Immuno Oncology Assays Players by Revenue (2018-2023)
3.1.2 Global Immuno Oncology Assays Revenue Market Share by Players (2018-2023)
3.2 Global Immuno Oncology Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immuno Oncology Assays Revenue
3.4 Global Immuno Oncology Assays Market Concentration Ratio
3.4.1 Global Immuno Oncology Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno Oncology Assays Revenue in 2022
3.5 Immuno Oncology Assays Key Players Head office and Area Served
3.6 Key Players Immuno Oncology Assays Product Solution and Service
3.7 Date of Enter into Immuno Oncology Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno Oncology Assays Breakdown Data by Type
4.1 Global Immuno Oncology Assays Historic Market Size by Type (2018-2023)
4.2 Global Immuno Oncology Assays Forecasted Market Size by Type (2024-2033)
5 Immuno Oncology Assays Breakdown Data by Application
5.1 Global Immuno Oncology Assays Historic Market Size by Application (2018-2023)
5.2 Global Immuno Oncology Assays Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Immuno Oncology Assays Market Size (2018-2033)
6.2 North America Immuno Oncology Assays Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Immuno Oncology Assays Market Size by Country (2018-2023)
6.4 North America Immuno Oncology Assays Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immuno Oncology Assays Market Size (2018-2033)
7.2 Europe Immuno Oncology Assays Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Immuno Oncology Assays Market Size by Country (2018-2023)
7.4 Europe Immuno Oncology Assays Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno Oncology Assays Market Size (2018-2033)
8.2 Asia-Pacific Immuno Oncology Assays Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Immuno Oncology Assays Market Size by Region (2018-2023)
8.4 Asia-Pacific Immuno Oncology Assays Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immuno Oncology Assays Market Size (2018-2033)
9.2 Latin America Immuno Oncology Assays Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Immuno Oncology Assays Market Size by Country (2018-2023)
9.4 Latin America Immuno Oncology Assays Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno Oncology Assays Market Size (2018-2033)
10.2 Middle East & Africa Immuno Oncology Assays Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Immuno Oncology Assays Market Size by Country (2018-2023)
10.4 Middle East & Africa Immuno Oncology Assays Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fischer Scientific
11.1.1 Thermo Fischer Scientific Company Detail
11.1.2 Thermo Fischer Scientific Business Overview
11.1.3 Thermo Fischer Scientific Immuno Oncology Assays Introduction
11.1.4 Thermo Fischer Scientific Revenue in Immuno Oncology Assays Business (2018-2023)
11.1.5 Thermo Fischer Scientific Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Detail
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Immuno Oncology Assays Introduction
11.2.4 Roche Diagnostics Revenue in Immuno Oncology Assays Business (2018-2023)
11.2.5 Roche Diagnostics Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Immuno Oncology Assays Introduction
11.3.4 Agilent Technologies Revenue in Immuno Oncology Assays Business (2018-2023)
11.3.5 Agilent Technologies Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Immuno Oncology Assays Introduction
11.4.4 Illumina Revenue in Immuno Oncology Assays Business (2018-2023)
11.4.5 Illumina Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immuno Oncology Assays Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Immunoassay
Table 3. Key Players of Flow Cytometry
Table 4. Key Players of PCR
Table 5. Key Players of Next Generation Sequencing
Table 6. Global Immuno Oncology Assays Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Immuno Oncology Assays Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Immuno Oncology Assays Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Immuno Oncology Assays Market Share by Region (2018-2023)
Table 10. Global Immuno Oncology Assays Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Immuno Oncology Assays Market Share by Region (2024-2033)
Table 12. Immuno Oncology Assays Market Trends
Table 13. Immuno Oncology Assays Market Drivers
Table 14. Immuno Oncology Assays Market Challenges
Table 15. Immuno Oncology Assays Market Restraints
Table 16. Global Immuno Oncology Assays Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Immuno Oncology Assays Market Share by Players (2018-2023)
Table 18. Global Top Immuno Oncology Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Oncology Assays as of 2022)
Table 19. Ranking of Global Top Immuno Oncology Assays Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Immuno Oncology Assays Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Immuno Oncology Assays Product Solution and Service
Table 23. Date of Enter into Immuno Oncology Assays Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immuno Oncology Assays Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Immuno Oncology Assays Revenue Market Share by Type (2018-2023)
Table 27. Global Immuno Oncology Assays Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Immuno Oncology Assays Revenue Market Share by Type (2024-2033)
Table 29. Global Immuno Oncology Assays Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Immuno Oncology Assays Revenue Market Share by Application (2018-2023)
Table 31. Global Immuno Oncology Assays Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Immuno Oncology Assays Revenue Market Share by Application (2024-2033)
Table 33. North America Immuno Oncology Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Immuno Oncology Assays Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Immuno Oncology Assays Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Immuno Oncology Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Immuno Oncology Assays Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Immuno Oncology Assays Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Immuno Oncology Assays Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Immuno Oncology Assays Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Immuno Oncology Assays Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Immuno Oncology Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Immuno Oncology Assays Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Immuno Oncology Assays Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Immuno Oncology Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Immuno Oncology Assays Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Immuno Oncology Assays Market Size by Country (2024-2033) & (US$ Million)
Table 48. Thermo Fischer Scientific Company Detail
Table 49. Thermo Fischer Scientific Business Overview
Table 50. Thermo Fischer Scientific Immuno Oncology Assays Product
Table 51. Thermo Fischer Scientific Revenue in Immuno Oncology Assays Business (2018-2023) & (US$ Million)
Table 52. Thermo Fischer Scientific Recent Development
Table 53. Roche Diagnostics Company Detail
Table 54. Roche Diagnostics Business Overview
Table 55. Roche Diagnostics Immuno Oncology Assays Product
Table 56. Roche Diagnostics Revenue in Immuno Oncology Assays Business (2018-2023) & (US$ Million)
Table 57. Roche Diagnostics Recent Development
Table 58. Agilent Technologies Company Detail
Table 59. Agilent Technologies Business Overview
Table 60. Agilent Technologies Immuno Oncology Assays Product
Table 61. Agilent Technologies Revenue in Immuno Oncology Assays Business (2018-2023) & (US$ Million)
Table 62. Agilent Technologies Recent Development
Table 63. Illumina Company Detail
Table 64. Illumina Business Overview
Table 65. Illumina Immuno Oncology Assays Product
Table 66. Illumina Revenue in Immuno Oncology Assays Business (2018-2023) & (US$ Million)
Table 67. Illumina Recent Development
Table 68. Research Programs/Design for This Report
Table 69. Key Data Information from Secondary Sources
Table 70. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno Oncology Assays Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Immuno Oncology Assays Market Share by Type: 2022 VS 2033
Figure 3. Immunoassay Features
Figure 4. Flow Cytometry Features
Figure 5. PCR Features
Figure 6. Next Generation Sequencing Features
Figure 7. Global Immuno Oncology Assays Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Immuno Oncology Assays Market Share by Application: 2022 VS 2033
Figure 9. Research Case Studies
Figure 10. Clinical Diagnostics Case Studies
Figure 11. Immuno Oncology Assays Report Years Considered
Figure 12. Global Immuno Oncology Assays Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Immuno Oncology Assays Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Immuno Oncology Assays Market Share by Region: 2022 VS 2033
Figure 15. Global Immuno Oncology Assays Market Share by Players in 2022
Figure 16. Global Top Immuno Oncology Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno Oncology Assays as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Immuno Oncology Assays Revenue in 2022
Figure 18. North America Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Immuno Oncology Assays Market Share by Country (2018-2033)
Figure 20. United States Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Immuno Oncology Assays Market Share by Country (2018-2033)
Figure 24. Germany Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Immuno Oncology Assays Market Share by Region (2018-2033)
Figure 32. China Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Immuno Oncology Assays Market Share by Country (2018-2033)
Figure 40. Mexico Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Immuno Oncology Assays Market Share by Country (2018-2033)
Figure 44. Turkey Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Immuno Oncology Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Thermo Fischer Scientific Revenue Growth Rate in Immuno Oncology Assays Business (2018-2023)
Figure 47. Roche Diagnostics Revenue Growth Rate in Immuno Oncology Assays Business (2018-2023)
Figure 48. Agilent Technologies Revenue Growth Rate in Immuno Oncology Assays Business (2018-2023)
Figure 49. Illumina Revenue Growth Rate in Immuno Oncology Assays Business (2018-2023)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed